Akt-mediated foxo1 inhibition is required for liver regeneration

Montse Pauta1,2, Noemi Rotllan2,3,4, Ana Fernández-Hernando2

  • 1Department of Biochemistry and Molecular Genetics, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigaciones Biomédicas en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Abstract

Insights

The Akt-FoxO1 signaling pathway is crucial for liver regeneration. Deleting FoxO1 in liver cells restored regeneration in mice lacking Akt1 or Akt2, highlighting this pathway's essential role.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cell Signaling

Background:

  • Liver regeneration is vital for treating chronic liver diseases.
  • Successful regeneration requires coordinated signaling pathways.
  • The serine-threonine kinase Akt (protein kinase B) acts as a key signal integration node.

Purpose of the Study:

  • To investigate the role of Akt isoforms (Akt1 and Akt2) in hepatic regeneration.
  • To determine the impact of Akt deficiency on liver cell function during regeneration.

Main Methods:

  • Partial hepatectomy was performed on mice lacking Akt1, Akt2, or both.
  • Hepatic-specific knockout models were used to assess Akt's role.
  • The effect of FoxO1 deletion on regeneration was examined in Akt-deficient mice.

Main Results:

  • Absence of individual Akt1 or Akt2 isoforms did not impair liver regeneration.
  • Mice lacking both Akt1 and Akt2 specifically in the liver showed impaired regeneration and increased mortality.
  • Akt deficiency led to reduced cell proliferation, hypertrophy, glycogenesis, and lipid droplet formation.
  • Liver-specific deletion of FoxO1 rescued regenerative capacity and normalized cellular events in Akt-deficient mice.

Conclusions:

  • The Akt-FoxO1 signaling pathway is essential for effective liver regeneration.
  • Targeting the Akt-FoxO1 pathway may offer therapeutic strategies for liver diseases.